BIOCRYST PHARMACEUTICALS INC·4

May 15, 7:11 AM ET

Barnes Alane P 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed May 15, 2024

Insider Transaction Report

Form 4
Period: 2024-05-13
Barnes Alane P
VP, General Counsel & Corp Sec
Transactions
  • Purchase

    Common Stock

    2024-05-13$5.53/sh+5,000$27,650300,762 total
Footnotes (1)
  • [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.36 to $5.64. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT